| Bid | 17 |
| Market Cap | 684.24M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.06 |
| PE Ratio (ttm) | -18.02 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 24 |
| Volume | 185,280 |
| Avg. Volume (20D) | 230,745 |
| Open | 21.13 |
| Previous Close | 20.84 |
| Day's Range | 18.69 - 21.13 |
| 52-Week Range | 18.69 - 32.75 |
| Beta | undefined |
About CBLL
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its nam...
Analyst Forecast
According to 5 analyst ratings, the average rating for CBLL stock is "Buy." The 12-month stock price forecast is $32.5, which is an increase of 70.16% from the latest price.
1 month ago · seekingalpha.com
CeriBell: Healthcare Technology Stock With A Promising Growth OutlookInitiating coverage on CeriBell with a "Buy" rating, citing a promising growth outlook and a 24-month investment horizon. CeriBell's Ceribell System, an AI-powered EEG platform, shows strong revenue g...
